P
Peter B. Gregory
Researcher at Stanford University
Publications - 55
Citations - 3286
Peter B. Gregory is an academic researcher from Stanford University. The author has contributed to research in topics: Hepatitis B & Hepatitis. The author has an hindex of 29, co-authored 55 publications receiving 3253 citations. Previous affiliations of Peter B. Gregory include City University of New York & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis
Harry B. Greenberg,Richard B. Pollard,Larry I. Lutwick,Peter B. Gregory,William S. Robinson,Thomas C. Merigan +5 more
TL;DR: Parenteral interferon therapy was associated with a rapid and reproducible fall in all Dane-particle markers in four patients with chronic hepatitis B infection and chronic active hepatitis and may be useful in limiting carrier infectivity or eradicating chronic infection.
Journal ArticleDOI
Survival in chronic hepatitis B. An analysis of 379 patients.
Jed I. Weissberg,Ljudevit L. Andres,C. Smith,Sheila Weick,Joanne E. Nichols,Gabriel Garcia,William S. Robinson,Thomas C. Merigan,Peter B. Gregory +8 more
TL;DR: Survival data from 379 patients with chronic hepatitis B were analyzed to determine life expectancy for the patient from the time of first contact, and a multivariate analysis found age of 40 years or more, total bilirubin level of 1.5 mg/dLor more, ascites, and spider nevi to be factors that identified patients at a higher risk of death.
Journal ArticleDOI
Accelerated improvement of alcoholic liver disease with enteral nutrition
Patrick J. Kearns,Harvey S. Young,Harvey S. Young,Harvey S. Young,Gabriel Garcia,Gabriel Garcia,Gabriel Garcia,Terrence F. Blaschke,Terrence F. Blaschke,Terrence F. Blaschke,Gail O'Hanlon,Gail O'Hanlon,Gail O'Hanlon,Mary Rinki,Mary Rinki,Mary Rinki,Kathryn Sucher,Kathryn Sucher,Kathryn Sucher,Peter B. Gregory,Peter B. Gregory,Peter B. Gregory +21 more
TL;DR: Findings support the use of standard, casein-based solutions in the treatment of alcoholic liver disease and as the control condition for future studies, and support the demonstrated benefits of a 2-cal/mL, caseIn-based tube-fed supplement.
Journal ArticleDOI
Effects of Immunosuppressive Therapy on Viral Markers in Chronic Active Hepatitis B
TL;DR: It is suggested that immunosuppressive therapy has a potentiating effect on hepatitis B viral replication in patients with chronic active hepatitis.
Journal ArticleDOI
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
George H. Scullard,Richard B. Pollard,Joseph L. Smith,S. L. Sacks,Peter B. Gregory,W. S. Robinson,Thomas C. Merigan +6 more
TL;DR: Patients with chronic active hepatitis, those who are female, and those with a history of recent steroid therapy responded to the antiviral agents significantly better than did the other patients.